Search

Merlyn Flom Phones & Addresses

  • 404 Roxbury Ln, Noblesville, IN 46060
  • Las Vegas, NV
  • Sartell, MN

Publications

Us Patents

Crystalline Form Of 6-Hydroxy-3-(4-[2-(Piperidin-1-Yl)Ethoxy]Phenoxy)-2-(4-Methoxyphenyl)Benzo[B]Thiophene Hydrochloride

View page
US Patent:
6610706, Aug 26, 2003
Filed:
Jan 10, 2002
Appl. No.:
10/031324
Inventors:
Julie Kay Bush - Fishers IN
Preston Charles Conrad - Indianapolis IN
Merlyn Gerard Flom - Noblesville IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 31445
US Classification:
514324, 546202
Abstract:
The present invention is directed to a novel crystalline hydrate of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]-phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride and uses for same, including inhibition of disease states associated with estrogen deprivation including cardiovascular disease, hyperlipidemia, and osteoporosis; and inhibition of other pathological conditions such as endometriosis, uterine fibrosis, estrogen-dependent cancer (including breast and uterine cancer), prostate cancer, benign prostatic hyperplasia, CNS disorders including Alzheimers disease, prevention of breast cancer, and up-regulating ChAT.

Crystalline Form Of 6-Hydroxy-3-(4-[2-(Piperidin-1-Yl)Ethoxy]Phenoxy)-2-(4-Methoxyphenyl)Benzo[B] Thiophene Hydrochloride

View page
US Patent:
6653479, Nov 25, 2003
Filed:
Jan 10, 2002
Appl. No.:
10/031326
Inventors:
Julie Kay Bush - Fishers IN
Preston Charles Conrad - Indianapolis IN
Merlyn Gerard Flom - Noblesville IN
Wayne Douglas Luke - West Lafayette IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07D40900
US Classification:
546202, 548525
Abstract:
The present invention is directed to a novel crystalline hydrate of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride and uses for same, including inhibition of disease states associated with estrogen deprivation including cardiovascular disease, hyperlipidemia, and osteoporosis; and inhibition of other pathological conditions such as endometriosis, uterine fibrosis, estrogen-dependent cancer (including breast and uterine cancer), prostate cancer, benign prostatic hyperplasia, CNS disorders including Alzheimers disease, prevention of breast cancer, and up-regulating ChAT.

Moisturizing Lotion

View page
US Patent:
45955867, Jun 17, 1986
Filed:
Aug 30, 1985
Appl. No.:
6/771450
Inventors:
Merlyn G. Flom - Noblesville IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 742
A61K 744
US Classification:
424 59
Abstract:
The present invention provides a novel moisturizing lotion which increases the rate of cell renewal on the skin without causing skin irritation and which facilitates the subsequent application of make-up.

Cosmetic Cleanser Formulation

View page
US Patent:
43829600, May 10, 1983
Filed:
Aug 3, 1981
Appl. No.:
6/289657
Inventors:
Merlyn G. Flom - Noblesville IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 4700
US Classification:
424358
Abstract:
A novel cosmetic skin cleanser formulation is described which is non-irritating and non-stinging.

Sensitive-Skin Care Regime

View page
US Patent:
43681875, Jan 11, 1983
Filed:
Aug 3, 1981
Appl. No.:
6/289658
Inventors:
Merlyn G. Flom - Noblesville IN
Anne M. Herrold - Brownsburg IN
Joe O. Martin - Martinsville IN
Anton A. Mentlik - Noblesville IN
Patricia P. Warrick - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 3178
A61K 4700
US Classification:
424 81
Abstract:
A method of decreasing the sensitivity of the skin without causing irritation is described, using a four component cosmetic regime. The four components comprising the regime are: a cleanser, a toner, a moisturizer, and a cream.

Cosmetic Cleanser Formulation

View page
US Patent:
42785707, Jul 14, 1981
Filed:
Aug 20, 1980
Appl. No.:
6/179628
Inventors:
Merlyn G. Flom - Noblesville IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C11D 184
A61K 748
US Classification:
252546
Abstract:
A skin cleanser formulation, which is one of four components used in a cosmetic regime, is disclosed. Applying the regime to the skin increases epidermal cell turnover without skin irritation. The other three components used in the regime are a cream, a lotion, and a tonic.

Skin Cell Renewal Regime

View page
US Patent:
42725445, Jun 9, 1981
Filed:
Aug 20, 1980
Appl. No.:
6/179627
Inventors:
John A. Cella - Carmel IN
Merlyn G. Flom - Noblesville IN
Anne M. Herrold - Brownsburg IN
Joe O. Martin - Martinsville IN
Ovidio Vargas - Carmel IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 31415
US Classification:
424273R
Abstract:
A novel cell renewal cosmetic regime is disclosed, which increases epidermal cell turnover without skin irritation. The regime consists of the use of four components: a cleanser, a cream, a lotion, and a tonic.
Merlyn G Flom from Noblesville, IN, age ~87 Get Report